Trevi Therapeutics's total assets for Q2 2025 were $208.34M, an increase of 94.70% from the previous quarter. TRVI total liabilities were $9.85M for the fiscal quarter, a 30.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.